sting d2p2f (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
98
Structured Review
Cell Signaling Technology Inc
sting d2p2f
Sting D2p2f, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1324 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+sting+d2p2f/STING+Rabbit+mAb/pm41928245-451-16-19
Average 98 stars, based on 1324 article reviews
Sting D2p2f, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1324 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+sting+d2p2f/STING+Rabbit+mAb/pm41928245-451-16-19
Average 98 stars, based on 1324 article reviews
sting d2p2f - by Bioz Stars,
2026-10
98/100 stars
Images
Related Articles
other:Article Title: Porphyromonas gingivalis Outer Membrane Vesicles-Associated DNA Triggers Inflammation by Inducing IL-6 in Astrocytes. Article Snippet: The following primary antibodies were used: Article Title: STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1 + NK cells. Article Snippet: The following primary antibodies were obtained from Article Title: CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade. Article Snippet: The following antibodies were used at concentrations of 0.1–0.5 μg/mL: anti-pMCM2 (EPR4170(2)) (ab133243; Abcam), anti-MCM2 (E-8) (sc-373702; Santa Cruz Biotechnology), Article Title: CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade Article Snippet: The following antibodies were used at concentrations of 0.1–0.5 μg/mL: anti-pMCM2 (EPR4170(2)) (ab133243; Abcam), anti-MCM2 (E-8) (sc-373702; Santa Cruz Biotechnology), Article Title: Systematic Discovery of Pathogen Effector Functions across Human Pathogens and Pathways Article Snippet: Membranes were probed with the following primary antibodies: anti-V5-tag (Thermo Fisher, R960-25, 1:1,000), anti-IKKα (Cell Signaling Technology, 11930), Western Blot:Article Title: Inhibition of O -GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway Article Snippet: The images were acquired with ChemiDoc MP System (Bio-Rad). .. Primary antibodies for western blot included anti-OGT (5368, Cell Signaling Technology), anti- O -GlcNAc (ab2739, Abcam), anti-MAVS (sc-365334, Santa Cruz Biotechnology), anti-phospho-TBK1/NAK (Ser172) (5483, Cell Signaling Technology), anti-TBK1 (3504, Cell Signaling Technology), anti-phospho-IRF3 (Ser396) (4947, Cell Signaling Technology), Article Title: Inhibition of O -GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway Article Snippet: The images were acquired with ChemiDoc MP System (Bio-Rad). .. Primary antibodies for western blot included anti-OGT (5368, Cell Signaling Technology), anti- O -GlcNAc (ab2739, Abcam), anti-MAVS (sc-365334, Santa Cruz Biotechnology), anti-phospho-TBK1/NAK (Ser172) (5483, Cell Signaling Technology), anti-TBK1 (3504, Cell Signaling Technology), anti-phospho-IRF3 (Ser396) (4947, Cell Signaling Technology), anti-IRF3 (4962, Cell Signaling Technology, anti-anti-phospho-STAT1 (Ser727) ( Staining:Article Title: Genome-wide CRISPR activation screen identifies ARL11 as a sensitivity determinant of PARP inhibitor therapy. Article Snippet: Resistance to poly-(ADP)-ribose polymerase inhibitors (PARPi) remains a significant challenge in clinical practice, leading to treatment failure in many patients.. It is crucial to better understand the molecular mechanisms that underlie PARPi resistance.. In this study, utilizing a genome-wide CRISPR activation screen with olaparib, we identified ARL11 as a potential modulator of PARPi treatment response in BRCA-wild-type MDA-MB-231 cells. |